Approach Bias Retraining and Smoking Cessation
Study Title: Approach Bias Retraining to Augment Smoking Cessation
Sponsor: National Institute on Drug Abuse
Objective: The study examines the use of a computerized joystick task to augment the effects of standard smoking cessation counseling and nicotine replacement therapy. The joystick task training is designed to weaken automatic cigarette- approach and strengthen automatic cigarette avoidance. Eligible participants will receive free smoking counseling session once a week for seven weeks. In addition, participants will receive 8 weeks of Nicoderm CQ®, 24-hour transdermal nicotine patches (TNP). Participation in this study has the potential to help individuals quit smoking and, ultimately, provide unique information about the importance of targeting implicit processes to complement standard care. Participants will receive up to $250 in compensation by the completion of the study.
Clinical Trials Registry: https://clinicaltrials.gov/ct2/show/NCT03325777?term=approach+bias+retraining&recrs=ab&rank=1
Status: This study is currently recruiting participants.
IRB Protocol: 2017-04-0006
YMCA Exercise Intervention for Smoking Cessation Study
Study Title: CPRIT-YMCA Study
Sponsor: Cancer Prevention Research Institute of Texas (CPRIT)
Objective: The study examines the use of exercise to enhance the outcome of smoking cessation within smokers who are sensitive to stress and anxiety. Specifically, this study aims to evaluate the feasibility and effectiveness of a community-based personalized exercise-smoking cessation intervention. Eligible participants will be paired with a personal trainer and undergo 15 weeks of exercise sessions at an Austin-area YMCA. In addition, participants will receive smoking cessation counseling through the Texas Tobacco Quitline. The study also provides 8 weeks of Nicoderm CQ®, 24-hour transdermal nicotine patches (TNP). Participation in this study will help investigators determine whether an exercise and smoking cessation program can be widely implemented in a community-based organization, such as the YMCA. Participants will receive up to $250 in compensation by the completion of the study
Clinical Trials Registry: https://clinicaltrials.gov/ct2/show/NCT03080090?term=YMCA&rank=5
Status: This study is NO LONGER recruiting participants.
IRB Protocol: 2016-12-0049
Cigarette Craving Reduction Study
Study Title: Enhancing Cigarette Craving Reduction with Isradipine
Objective: The study examines the efficacy of 15 mg of Isradipine in comparison to placebo for tobacco craving reduction. Eligible participants will come in for two consecutive sessions and participate in cue exposure treatment, which involves measuring your cravings in response to smoking related cues. For the first visit only, participants will receive either isradipine or a placebo pill 75 minutes before the first cue exposure treatment. The second session will take place 24 hours after the first and will not include medication. Participants will receive $50 upon completion of the study.
Clinical Trials Registry: https://clinicaltrials.gov/ct2/show/NCT03083353
Status: This study is currently recruiting participants.
IRB Protocol: 2016-09-0150